Mast cells in pancreatic ductal adenocarcinoma

Using in vivo models of pancreatic ductal adenocarcinoma (PDAC), we demonstrated that mast cells migrate to the tumor site and provide a microenvironment that allows for tumor progression. These results indicate that targeting mast cells may be a promising novel therapy for PDAC.

Detalles Bibliográficos
Autor principal: Chang, David Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2012
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429584/
https://www.ncbi.nlm.nih.gov/pubmed/22934272
http://dx.doi.org/10.4161/onci.19612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429584/
https://www.ncbi.nlm.nih.gov/pubmed/22934272
http://dx.doi.org/10.4161/onci.19612

Ejemplares similares